Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | OpportunityAnalyzer: Celiac Disease-Opportunity Analysis and Forecast to 2023Overview of celiac disease, including epidemiology, etiology, pathophysiology, symptoms and current treatment options
By: Reportstack Key Findings - High uptake is expected of pipeline drugs for celiac disease that are anticipated to launch during the 2013-2023 forecast period. - Celiac disease remains a field of highly unattained unmet need. - There is no consensus over clinical trial design and endpoints for the development of celiac disease products. - The clinical stage pipeline is mainly focussed on GFD adjunctive therapies, while the pre-clinical stage pipeline has shifted its focus to disease modifying treatments. - Significant opportunity exists for products targeting in the non-refractory patient segment of the celiac disease market. - M&A’s and alliance opportunities will be key factors in driving celiac disease drug development. To access full report with TOC, please visit OpportunityAnalyzer: Scope - Overview of celiac disease, including epidemiology, etiology, pathophysiology, symptoms and current treatment options - Annualized celiac disease therapeutics market revenue, annual cost of therapies and forecasts for five years to 2018 and ten years to 2023. - Key topics covered include strategic product assessment, market characterization, unmet needs, R&D strategies, clinical trial design and implications for the celiac disease therapeutics market. - Pipeline analysis: comprehensive data split across different phases, emerging trends and mechanisms of action under development, including zonulin inhibitors, gluten peptide enzymes, gluten specific synthetic polymers and therapeutic vaccines. - Analysis of the current and future market competition in the US and five major EU celiac disease therapeutics market. Clinical and commercial benchmarking of promising pipeline products versus standard of care treatments and competitive assessment of all therapies. Insightful review of the key industry drivers, restraints and challenges. Reasons to buy The report will enable you to - - Identify the unmet needs and remaining opportunities in the celiac disease therapeutics market. - Develop business strategies by understanding the trends shaping and driving the US and five major EU celiac disease therapeutics market. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Assess the clinical and commercial viability of promising pipeline products. - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various emerging therapies. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - Drive revenues by understanding the key trends, innovative products and technologies, market and segments likely to impact the US and five major EU celiac disease therapeutics market in future." About Reportstack: Reportstack (http://www.reportstack.com/ Contact: Debora White Manager - Marketing debora@reportstack.com Ph: +1-888-789-6604 Reportstack Market Research End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|